PPHM, LGO AND UKOG UPDATES

PPHM

PPHM's collaboration with AstraZeneca will include a later second stage trial. The trial will combine PPHM's Bavituximab and AstraZeneca's Durvalumabin a global Phase II study in patients with previously treated squamous or non-squamos non-small cell lung cancer (NSCLC). The randomised Stage II trial will be conducted by PPHM

LGO

LGO recently acquired a 25% stake in Beach oilfield Limited (BOLT) with which LGO already holds an agreement to acquire the deep petroleum rights to all of BOLT's South West Peninsula interests in Trinidad. With this 25% stake, LGO is now able to access an interest in the shallow petroleum rights held by BOLT including the producing Bonasse Oilfield.

UKOG

UKOG has received a conceptual oil development studies from Xodus Group Ltd and Barton Willmore. The studies are based on developing multiple sites across the UKOG's licences, each of which would consist of a conceptual multi-well pad with 12 horizontal production wells delivering 2,500 bopd at peak production. it remains a plan for the time being but it does show that UKOG is looking at ways to maximise production across their licences

My disclosure: I own shares of PPHM, LGO and UKOG